The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2019 | Key challenges of using the intestinal microbiome as a biomarker
Melody Smith
• 25 Mar 2019
Here, Melody Smith, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses the main challenges that are present when utilizing the intestinal microbiome as a biomarker. Dr Smith was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
